1. Home
  2. KYMR vs MXL Comparison

KYMR vs MXL Comparison

Compare KYMR & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$119.06

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

BUY

Current Price

$86.13

Market Cap

8.5B

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
KYMR
MXL
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.5B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
KYMR
MXL
Price
$119.06
$86.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
26
6
Target Price
$107.72
$41.67
AVG Volume (30 Days)
1.2M
3.6M
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.08
EPS
N/A
N/A
Revenue
$39,211,000.00
$478,596,000.00
Revenue This Year
$10.61
$22.10
Revenue Next Year
$8.17
$10.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.88
$12.77
52 Week High
$130.05
$128.30

Technical Indicators

Market Signals
Indicator
KYMR
MXL
Relative Strength Index (RSI) 76.01 46.98
Support Level $72.91 $74.01
Resistance Level $130.05 $105.27
Average True Range (ATR) 7.67 11.56
MACD 2.01 -0.67
Stochastic Oscillator 76.15 8.43

Price Performance

Historical Comparison
KYMR
MXL

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: